These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8496537)
21. Intravital and postmortem diagnostics of myocardial hypertrophy of the left ventricle:identity or convention? Bogomolov SN; Kulikov AN; Tikhonova JA; Solntsev VN; Rybakova MG; Gudkova AY; Kuchmin AN Ter Arkh; 2018 Sep; 90(9):73-80. PubMed ID: 30701739 [TBL] [Abstract][Full Text] [Related]
22. Ventricular mass and electrocardiographic criteria of hypertrophy: evaluation of new score. Mazzaro Cdo L; Costa Fde A; Bombig MT; Luna Filho B; Paola AA; Carvalho AC; Costa Wd; Fonseca FA; Póvoa RM Arq Bras Cardiol; 2008 Apr; 90(4):227-31. PubMed ID: 18516381 [TBL] [Abstract][Full Text] [Related]
23. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. Casale PN; Devereux RB; Kligfield P; Eisenberg RR; Miller DH; Chaudhary BS; Phillips MC J Am Coll Cardiol; 1985 Sep; 6(3):572-80. PubMed ID: 3161926 [TBL] [Abstract][Full Text] [Related]
24. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. Verdecchia P; Angeli F; Cavallini C; Mazzotta G; Repaci S; Pede S; Borgioni C; Gentile G; Reboldi G J Hypertens; 2009 Aug; 27(8):1697-704. PubMed ID: 19424088 [TBL] [Abstract][Full Text] [Related]
25. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193 [TBL] [Abstract][Full Text] [Related]
26. Time-voltage area of the QRS for the identification of left ventricular hypertrophy. Okin PM; Roman MJ; Devereux RB; Kligfield P Hypertension; 1996 Feb; 27(2):251-8. PubMed ID: 8567048 [TBL] [Abstract][Full Text] [Related]
27. Novel Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy in the Japanese General Population. Narita M; Yamada M; Tsushima M; Kudo N; Kato T; Yokono Y; Toyama Y; Senoo M; Yonekura M; Narita N; Kimura Y; Sawada K; Tokuda I; Tomita H Int Heart J; 2019 May; 60(3):679-687. PubMed ID: 31019179 [TBL] [Abstract][Full Text] [Related]
28. Combination of electrocardiographic and echocardiographic information identifies individuals prone to a progressive increase in left ventricular mass over 5 years. Reffelmann T; Dörr M; Völzke H; Kors J; Ruppert J; Robinson D; Felix SB J Hypertens; 2009 Apr; 27(4):861-8. PubMed ID: 19262408 [TBL] [Abstract][Full Text] [Related]
29. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Alfakih K; Walters K; Jones T; Ridgway J; Hall AS; Sivananthan M Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274 [TBL] [Abstract][Full Text] [Related]
30. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673 [TBL] [Abstract][Full Text] [Related]
31. Improved electrocardiographic detection of left ventricular hypertrophy. Warner RA; Ariel Y; Gasperina MD; Okin PM J Electrocardiol; 2002; 35 Suppl():111-5. PubMed ID: 12539107 [TBL] [Abstract][Full Text] [Related]
32. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Okin PM; Gerdts E; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B; Devereux RB; Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323 [TBL] [Abstract][Full Text] [Related]
33. [Left ventricular hypertrophy in hemodialysis patient: Prevalence, electrocardiographic, echocardiographic study and associated risk factors]. Chargui S; Allouche E; Dkhil W; Agrebi S; Ben Ahmed H; Ezzaouia K; Hajji M; Ezzamouri A; Basdah L; Ben Hamida F; Harzallah A; Abderrahim E Nephrol Ther; 2022 Jul; 18(4):247-254. PubMed ID: 35078738 [TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Levy D; Salomon M; D'Agostino RB; Belanger AJ; Kannel WB Circulation; 1994 Oct; 90(4):1786-93. PubMed ID: 7923663 [TBL] [Abstract][Full Text] [Related]
35. Performance of a novel ECG criterion for improving detection of left ventricular hypertrophy: a cross-sectional study in a general Chinese population. Chen Y; Sun G; Guo X; Li Z; Li G; Zhou Y; Yang H; Yu S; Zheng L; Sun Y BMJ Open; 2021 Sep; 11(9):e051172. PubMed ID: 34475185 [TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM; Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947 [TBL] [Abstract][Full Text] [Related]
37. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy. Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855 [TBL] [Abstract][Full Text] [Related]
38. An analysis of electrocardiographic criteria for determining left ventricular hypertrophy. Gasperin CA; Germiniani H; Facin CR; Souza AM; Cunha CL Arq Bras Cardiol; 2002 Jan; 78(1):59-82. PubMed ID: 11826348 [TBL] [Abstract][Full Text] [Related]
39. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Devereux RB; Koren MJ; de Simone G; Okin PM; Kligfield P Eur Heart J; 1993 Jul; 14 Suppl D():8-15. PubMed ID: 8370376 [TBL] [Abstract][Full Text] [Related]
40. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients. Ishikawa J; Yamanaka Y; Toba A; Watanabe S; Harada K Int Heart J; 2017 Dec; 58(6):933-938. PubMed ID: 29162779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]